Interdependent Factors of Demand-Side Rationale for Chemical, Biological, Radiological, and Nuclear Medical Countermeasures.

and nuclear agents biological chemical funding market demand medical countermeasures public health policy radiological

Journal

Disaster medicine and public health preparedness
ISSN: 1938-744X
Titre abrégé: Disaster Med Public Health Prep
Pays: United States
ID NLM: 101297401

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 19 11 2019
medline: 26 10 2021
entrez: 19 11 2019
Statut: ppublish

Résumé

The deliberate use of chemical, biological, radiological, and nuclear (CBRN) materials in war or terrorist attacks is perceived as a great threat globally. In the event of a release of CBRN agents, protection by means of medical countermeasures (MedCMs) could reduce health vulnerability. Nonetheless, for some diseases caused by these agents, innovative MedCMs do not exist and many of those that do might not be readily available. Inappropriate research and development funding and government procurement efforts can result in adverse economic consequences (eg, lost income, cost per loss of life, medical expenses) far exceeding the costs of strong and comprehensive preparedness initiatives. By illustrating factors of demand-side rationale for CBRN MedCMs, this article aims to strengthen integrity of policy-making associated with current demand requirements. Namely, an approach to inspire broader assessment is outlined by compiling and adapting existing economic models and concepts to characterize both soft and hard factors that influence demand-side rationale. First, the soft factor context is set by describing the impact of behavioral and political economics. Then, lessons learned from past public health funding models and associated collaborative access infrastructure are depicted to represent hard factors that can enhance the viability of MedCM preparedness evaluations.

Identifiants

pubmed: 31735188
pii: S1935789319001095
doi: 10.1017/dmp.2019.109
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

739-755

Auteurs

Mark Lawrence Johnson (ML)

MJ Lawrence Consulting, Munich, Germany.
Université Panthéon-Assas, LEMMA & Labex MME-DII, Paris, France.

Jean Belin (J)

University of Bordeaux(Gretha - UMR CNRS 5113), Pessac cedex, France.
Armament and defence economy chair (cercle des partenaires de l'IHEDN), Paris, France.

Frederic Dorandeu (F)

Armed Forces Biomedical Research Institute (IRBA), Brétigny-sur-Orge, France.
Ecole du Val-de-Grace, Paris, France.

Marianne Guille (M)

Université Panthéon-Assas, LEMMA & Labex MME-DII, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH